Építés alatt – nem éles oldal
Belépés
Befejeződött4. fázis

Effect of Vitamin D as Adjuvant Therapy in Preterm Infants With Neonatal Sepsis

A legfontosabb adatok

Ki végzi
Universitas Padjadjaran
Hol
Indonézia2 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Fázis
4. fázis
Résztvevők
78 fő vett részt
Kezdés
2025. aug. 2.
Befejezés
2025. dec. 8.
A vizsgálat típusa
Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Vitamin D
A regiszteradat frissítve
2026. február 5.

Ki vehet részt

Életkor
0 nap – 84 nap
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 5 feltétel megnézéseKevesebb

Ki vehet részt

  • Patients diagnosed with neonatal sepsis based on positive blood or cerebrospinal fluid cultures, or who meet the criteria for suspected sepsis with a Rodwell hematologic scoring system result of ≥3
  • Parents or legal guardians are willing to participate in the study and sign the informed consent form

Ki nem vehet részt

  • Patients with major congenital malformations such as anencephaly, encephalocele, holoprosencephaly, hydrocephalus, meningomyelocele, spina bifida, omphalocele, gastroschisis, or congenital heart disease
  • If during the 7-day monitoring period, a patient who was initially able to feed develops a medical condition requiring fasting (NPO)
  • If during the 7-day monitoring period, a patient who initially had a medical condition requiring fasting is later able to feed again

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of this clinical trial is to learn the effect of vitamin D as an adjunctive therapy for preterm neonates with sepsis measured by the outcomes, which are sepsis score and C-reactive protein after 7 days. The main questions it aims to answer are:

A teljes eredeti leírásKevesebb

Is there a difference in the results of the sepsis score (Modified Tollner Score and Sepsis Prediction Score) between groups of preterm neonates with sepsis who were given vitamin D as adjuvant therapy at doses of 400 IU/day, 800 IU/day, and those who were only given antibiotics?

Is there a difference in CRP levels between groups of preterm neonates with sepsis who were given vitamin D as adjuvant therapy at doses of 400 IU/day, 800 IU/day, and those who were only given antibiotics?

Participants will be divided into 3 groups:

Group 1 consisted of subjects who were given only antibiotics due to medical conditions requiring fasting.

Group 2 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 400 IU once daily for 7 days.

Group 3 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 800 IU once daily for 7 days.

A vizsgálat 3 csoportja

  • Antibiotics onlyNincs vizsgálati kezelés, összehasonlításként

    Group 1 consisted of subjects who were given only antibiotics due to medical conditions requiring fasting.

  • Vitamin D 400 IUMár használt kezelés, összehasonlításként

    Group 2 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 400 IU once daily for 7 days.

    Kezelés: Vitamin D

  • Vitamin D 800 IUMár használt kezelés, összehasonlításként

    Group 3 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 800 IU once daily for 7 days.

    Kezelés: Vitamin D

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
The Effect of Vitamin D Administration on Sepsis Score and C-Reactive Protein Levels in Preterm Infants With Neonatal Sepsis
Publikációk
A regiszteradat frissítve
2026. február 5.